Alembic Pharmaceuticals Limited (APLLTD) — Annual Report

· NSE 🔴 High Importance Neutral
📢 Key Event
Alembic Pharmaceuticals schedules 16th AGM for 5 August 2026 via video conferencing to approve financials, dividend, and director appointments.
🔄 What Changed
Appointment of Mr. Sujit Jaysukh Bhayani as Independent Director and ratification of cost auditor remuneration for 2026-27.
🔮 What's Next
The Board recommends approval of the special resolution for Mr. Bhayani's appointment and the remuneration of cost auditors for 2026-27.
💡 Investor Takeaway
Shareholders must vote electronically to approve the new director and auditor pay, as the AGM will be held remotely without physical attendance.

Alembic Pharmaceuticals announced its 16th Annual General Meeting on 5 August 2026 via video conferencing, seeking shareholder approval for audited financial statements, dividend declaration, appointment of Mr. Sujit Jaysukh Bhayani as an Independent Director, and ratification of cost auditor remuneration. The meeting will be conducted electronically with no physical attendance or proxy facility, and shareholders must update KYC and bank details to receive dividends.

📄 View Original Announcement (PDF)

About Alembic Pharmaceuticals Limited (APLLTD)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹15,412.51 Cr P/E: 22.9 ROE: 11.8% ROCE: 11.2%

View full APLLTD stock details →

📡 Get AI alerts when APLLTD files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track APLLTD — Free

📊 More APLLTD filings

See all APLLTD filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when APLLTD files new disclosures

Track APLLTD filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track APLLTD — Free

Free account · 2 AI queries/day